| Name | Title | Contact Details |
|---|
Vital Incite: Population Health Solutions, is a health care consulting firm offering the insight needed to strategically align healthcare resources to meet the needs of employee populations. Data is the driving force behind the Vital Incite Population Health Solution. We use it to: • Identify health risks trends within an employee population. • Understand how employees are accessing healthcare. • Evaluate the effectiveness of health benefit and wellness programs. • Hold ourselves and vendor partners accountable to improve health risks and expenses Our analytics tools turn health care data into actionable intelligence so that employers can make informed decisions about the health and wellness programs they offer to employees. Our analytics tools combine multiple data sources, including: • Claims Data (medical, dental, vision) • Health Risk Assessments • Biometric Data • Vendor Data We use what we learn from the data to develop program objectives, set impact expectations and track the effectiveness of the program. We are focused on the big picture, helping employers manage their health care spend and helping employees improve their health. We don`t try to solve employer problems with our own solutions. We identify which resources are required, assist an employer in choosing the provider of those resources and then continue to monitor the impact of those programs.
Hamilton General Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hamilton, TX. To find more information about Hamilton General Hospital, please visit www.hamiltonhospital.org
Pronger Smith Medical Care is a Tinley Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Imedex is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.